1. H. Fujimura, N. Murakami, S. Miwa, C. Aruga and W. Toriumi, The suitability of rat hepatoma cell line H4IIE for evaluating the potentials of compounds to induce CYP3A23 expression, Exp. Toxicol. Pathol. 64 (2012) 527-533; https://doi.org/10.1016/j.etp.2010.11.01010.1016/j.etp.2010.11.010
2. D. B. Buckley and C. D. Klaassen, Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2, Drug Metab. Dispos. 37 (2009) 847-856; https://doi.org/10.1124/dmd.108.02419010.1124/dmd.108.024190
3. Food and Drug Administration, Guidance for Industry: Drug Interaction Studies - Study Design, Data Analysis, and Implications for Dosing and Labeling, Draft Guidance, FDA, Center for Drug Evaluation and Research, Rockville 2006; https://www.fda.gov/OHRMS/DOCKETS/98fr/06d-0344-gdl0001.pdf; last access date October 3, 2017
4. L. Richert, G. Tuschl, C. Abadie, N. Blanchard, D. Pekthong, G. Mantion, J. C. Wr andebe S. O. Mueller, Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes, Toxicol. Appl. Pharmacol. 235 (2009) 86-96; https://doi.org/10.1016/j.taap.2008.1 J. Skorkovská 1.019, V. Hanušová, V. Tománková, E. Anzenbacherová, B. Lišková, P. Anzenbacher10.1016/j.taap.2008.11.019
5. P. Matoušková, H. Bártíková, I. Boušová, B. Szotáková, J. Martin, and L. Skálová, Effect of defined green tea extract in various dosage schemes on drug-metabolizing enzymes in mice in vivo, J. Funct. Foods 10 (2014) 327-335; https://doi.org/10.1016/j.jff.2014.06.02610.1016/j.jff.2014.06.026
9. C. Abadie-Viollon, H. Martin, N. Blanchard, D. Pekthong, P. Bachellier, G. Mantion, B. Heyd, F. Schuler, P. Coassolo, E. Alexandre and L. Richert, Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions, Toxicol. In Vitro 24 (2010) 346-356; https://doi.org/10.1016/j.tiv.2009.05.02110.1016/j.tiv.2009.05.021
11. M. Monshouwer, G. A. Van’t Klooster, S. M. Nijmeijer, R. F. Witkamp and A. S. van Miert, Characterization of cytochrome P450 isoenzymes in primary cultures of pig hepatocytes, Toxicol. In Vitro 12 (1998) 715-723.10.1016/S0887-2333(98)00053-8
13. K. Lnenickova, E. Prochazkova, L. Skalova, P. Matouskova, H. Bartikova, P. Soucek and B. Szotakova, Catechins variously affect activities of conjugation enzymes in proliferating and differentiated Caco-2 cells, Molecules 21 (2016) e1186 (11 pages); https://doi.org/10.3390/molecules2109118610.3390/molecules21091186627295827617982
14. J. J. Cullen, M. M. Hinkhouse, M. Grady, A. W. Gaut, J. Liu, Y. P. Zhang, C. J. Weydert, F. E. Domann and L. W. Oberley, Dicumarol inhibition of NADPH:quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism, Cancer Res. 63 (2003) 5513-5520.
15. M. D. Burke and R. T. Mayer, Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene, Drug Metab. Dispos. 2 (1974) 583-588.
16. A. Untergasser, I. Cutcutache, T. Koressaar, J. Ye, B. C. Faircloth, M. Remm and S. G. Rozen, Primer3 - new capabilities and interfaces, Nucleic Acids Res. 40 (2012) e115 (12 pages); https://doi.org/10.1093/nar/gks59610.1093/nar/gks596342458422730293
17. K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method, Methods 25 (2001) 402-408; https://doi.org/10.1006/meth.2001.126210.1006/meth.2001.126211846609
18. Z. Dvorak, P. Maurel, M. J. Vilarem, J. Ulrichova and M. Modriansky, Expression and transcriptional activities of nuclear receptors involved in regulation of drug-metabolizing enzymes are not altered by colchiceine: Focus on PXR, CAR, and GR in primary human hepatocytes, Cell Biol. Toxicol. 23 (2007) 63-73; https://doi.org/10.1007/s10565-006-0127-810.1007/s10565-006-0127-816964586
19. M. Nishimura, A. Koeda, E. Suzuki, T. Shimizu, Y. Kawano, M. Nakayama and T. Satoh, Effects of prototypical drug-metabolizing enzyme inducers on mRNA expression of housekeeping genes in primary cultures of human and rat hepatocytes, Biochem. Bioph. Res. Commun. 346 (2006) 1033-1039; https://doi.org/10.1016/j.bbrc.2006.06.01210.1016/j.bbrc.2006.06.01216777070
20. Y. Korenori, S. Tanigawa, T. Kumamoto, S. Qin, Y. Daikoku, K. Miyamori, M. Nagai and D. X. Hou, Modulation of Nrf2/Keap1 system by Wasabi 6-methylthiohexyl isothiocyanate in ARE-mediated NQO1 expression, Mol. Nutr. Food Res. 57 (2013) 854-864; https://doi.org/10.1002/mnfr.20120068910.1002/mnfr.20120068923390006
22. E. P. Chen, L. F. Chen, Y. Ji, G. Y. Tai, Y. H. Wen and H. Ellens, A mechanism-based mathematical model of aryl hydrocarbon receptor-mediated CYP1A induction in rats using beta-naphthoflavone as a tool compound, Drug Metab. Dispos. 38 (2010) 2278-2285; https://doi.org/10.1124/dmd.110.03442110.1124/dmd.110.03442120843940
27. D. Brauze, K. Fijalkiewicz, M. Szaumkessel, K. Kiwerska, K. Bednarek, M. Rydzanicz, J. Richter, R. Grenman and M. Jarmuz-Szymczak, Diversified expression of aryl hydrocarbon receptor dependent genes in human laryngeal squamous cell carcinoma cell lines treated with beta-naphthoflavone, Toxicol. Lett. 231 (2014) 99-107; https://doi.org/10.1016/j.toxlet.2014.09.00510.1016/j.toxlet.2014.09.00525218365
28. D. Brauze, M. Widerak, J. Cwykiel, K. Szyfter and W. Baer-Dubowska, The effect of aryl hydrocarbon receptor ligands on the expression of AhR, AhRR, ARNT, Hif1 alpha, CYP1A1 and NQO1 genes in rat liver, Toxicol. Lett. 167 (2006) 212-220; https://doi.org/10.1016/j.toxlet.2006.09.01010.1016/j.toxlet.2006.09.01017069994